Amy K. Goodwin, Ph.D. - Publications

Western Michigan University, Kalamazoo, MI, United States 
Neuropharmacology, drugs of abuse

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Goodwin AK. An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates. Journal of Pharmacological and Toxicological Methods. 82: 31-36. PMID 27473331 DOI: 10.1016/j.vascn.2016.07.004  1
2015 Goodwin AK, Hiranita T, Paule MG. The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25673111 DOI: 10.1093/ntr/ntv002  1
2015 Goodwin AK, Lantz-McPeak SM, Robinson BL, Law CD, Ali SF, Ferguson SA. Effects of adolescent treatment with nicotine, harmane, or norharmane in male Sprague-Dawley rats. Neurotoxicology and Teratology. 47: 25-35. PMID 25450662 DOI: 10.1016/  1
2013 Goodwin AK, Gibson KM, Weerts EM. Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons. Drug and Alcohol Dependence. 132: 427-33. PMID 23538206 DOI: 10.1016/j.drugalcdep.2013.02.035  1
2013 Goodwin AK, Mueller M, Shell CD, Ricaurte GA, Ator NA. Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons. The Journal of Pharmacology and Experimental Therapeutics. 345: 342-53. PMID 23516331 DOI: 10.1124/jpet.113.203729  1
2013 Goodwin AK, Kaminski BJ, Weerts EM. Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 225: 637-46. PMID 22945514 DOI: 10.1007/s00213-012-2851-5  1
2011 Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences. The Journal of Pharmacology and Experimental Therapeutics. 338: 310-7. PMID 21493752 DOI: 10.1124/jpet.111.180612  1
2011 Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons. Drug and Alcohol Dependence. 114: 217-24. PMID 21112162 DOI: 10.1016/j.drugalcdep.2010.10.006  1
2009 Goodwin AK, Brown PR, Jansen EE, Jakobs C, Gibson KM, Weerts EM. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 204: 465-76. PMID 19198808 DOI: 10.1007/s00213-009-1477-8  1
2008 Kaminski BJ, Goodwin AK, Wand G, Weerts EM. Dissociation of alcohol-seeking and consumption under a chained schedule of oral alcohol reinforcement in baboons. Alcoholism, Clinical and Experimental Research. 32: 1014-22. PMID 18422839 DOI: 10.1111/j.1530-0277.2008.00662.x  1
2007 Weerts EM, Fantegrossi WE, Goodwin AK. The value of nonhuman primates in drug abuse research. Experimental and Clinical Psychopharmacology. 15: 309-27. PMID 17696678 DOI: 10.1037/1064-1297.15.4.309  1
2006 Weerts EM, Goodwin AK, Kaminski BJ, Hienz RD. Environmental cues, alcohol seeking, and consumption in baboons: effects of response requirement and duration of alcohol abstinence. Alcoholism, Clinical and Experimental Research. 30: 2026-36. PMID 17117968 DOI: 10.1111/j.1530-0277.2006.00249.x  1
2006 Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM, Weerts EM. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology. 189: 71-82. PMID 17047936 DOI: 10.1007/s00213-006-0534-9  1
2006 Struys EA, Verhoeven NM, Jansen EE, Ten Brink HJ, Gupta M, Burlingame TG, Quang LS, Maher T, Rinaldo P, Snead OC, Goodwin AK, Weerts EM, Brown PR, Murphy TC, Picklo MJ, et al. Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism: Clinical and Experimental. 55: 353-8. PMID 16483879 DOI: 10.1016/j.metabol.2005.09.009  1
2005 Goodwin AK, Froestl W, Weerts EM. Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology. 180: 342-51. PMID 15739078 DOI: 10.1007/s00213-005-2165-y  1
2005 Weerts EM, Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology. 179: 678-87. PMID 15645222 DOI: 10.1007/s00213-004-2079-0  1
2003 Goodwin AK, Pynnonen DM, Baker LE. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination. Pharmacology, Biochemistry, and Behavior. 74: 987-95. PMID 12667914 DOI: 10.1016/S0091-3057(03)00029-7  1
2002 Goodwin AK, Baker LE. An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13: 271-8. PMID 12218507  1
2001 Christian AJ, Goodwin AK, Baker LE. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology, Biochemistry, and Behavior. 68: 371-7. PMID 11325388 DOI: 10.1016/S0091-3057(00)00470-6  1
2000 Goodwin AK, Baker LE. A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats. Experimental and Clinical Psychopharmacology. 8: 415-23. PMID 10975633 DOI: 10.1037//1064-1297.8.3.415  1
1998 Baker LE, Svensson KA, Garner KJ, Goodwin AK. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. European Journal of Pharmacology. 358: 101-9. PMID 9808258 DOI: 10.1016/S0014-2999(98)00582-2  1
Show low-probability matches.